VolitionRx Limited Accumulated Other Comprehensive Income
VolitionRx Limited (VNRX) had Accumulated Other Comprehensive Income of -$88.45 thousand as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax · last filed 2026-08-13
- 2026-06-30: Accumulated Other Comprehensive Income (Loss), Net of Tax -$88.45K.
- 2026-03-31: Accumulated Other Comprehensive Income (Loss), Net of Tax -$160.76K.
- 2025-12-31: Accumulated Other Comprehensive Income (Loss), Net of Tax -$295.07K.
- 2025-09-30: Accumulated Other Comprehensive Income (Loss), Net of Tax -$421.95K.
| Period end | Accumulated Other Comprehensive Income (Loss), Net of Tax |
|---|---|
| 2026-06-30 | -$88.45K 10-Q · filed 2026-08-13 |
| 2026-03-31 | -$160.76K 10-Q · filed 2026-05-14 |
| 2025-12-31 | -$295.07K 10-Q · filed 2026-08-13 |
| 2025-09-30 | -$421.95K 10-Q · filed 2025-11-13 |
| 2025-06-30 | -$444.29K 10-Q · filed 2025-08-14 |
| 2025-03-31 | $131.70K 10-Q · filed 2025-05-15 |
| 2024-12-31 | $385.63K 10-K · filed 2026-03-31 |
| 2024-09-30 | $140.27K 10-Q · filed 2024-11-14 |
| 2024-06-30 | $282.25K 10-Q · filed 2024-08-14 |
| 2024-03-31 | $258.97K 10-Q · filed 2024-05-13 |
| 2023-12-31 | $243.94K 10-K · filed 2025-03-31 |
| 2023-09-30 | $239.62K 10-Q · filed 2023-11-14 |
| 2023-06-30 | $208.33K 10-Q · filed 2023-08-14 |
| 2023-03-31 | $170.62K 10-Q · filed 2023-05-10 |
| 2022-12-31 | $227.10K 10-K · filed 2024-03-25 |
| 2022-09-30 | $315.55K 10-Q · filed 2022-11-14 |
| 2022-06-30 | $244.52K 10-Q · filed 2022-08-10 |
| 2022-03-31 | $30.42K 10-Q · filed 2022-05-11 |
| 2021-12-31 | $148.33K 10-K · filed 2023-03-15 |
| 2021-09-30 | $8.73K 10-Q · filed 2021-11-10 |
| 2021-06-30 | $29.61K 10-Q · filed 2021-08-11 |
| 2021-03-31 | $74.16K 10-Q · filed 2021-05-11 |
| 2020-12-31 | -$59.98K 10-K · filed 2022-03-30 |
| 2020-09-30 | -$148.12K 10-Q · filed 2020-11-12 |
| 2020-06-30 | $425.28K 10-Q · filed 2020-08-13 |
| 2020-03-31 | $499.60K 10-Q · filed 2020-05-07 |
| 2019-12-31 | $125.67K 10-K · filed 2021-03-22 |
| 2019-09-30 | $650.82K 10-Q · filed 2019-11-12 |
| 2019-06-30 | $249.51K 10-Q · filed 2019-08-12 |
| 2019-03-31 | $199.60K 10-Q · filed 2019-05-08 |
| 2018-12-31 | $223.65K 10-K · filed 2020-02-20 |
| 2018-09-30 | $64.11K 10-Q · filed 2018-11-07 |
| 2018-06-30 | $17.76K 10-Q · filed 2018-08-13 |
| 2018-03-31 | -$114.40K 10-Q · filed 2018-05-10 |
| 2017-12-31 | -$129.34K 10-K · filed 2019-03-13 |
| 2017-09-30 | -$132.88K 10-Q · filed 2017-11-09 |
| 2017-06-30 | -$100.48K 10-Q · filed 2017-08-10 |
| 2017-03-31 | -$161.79K 10-Q · filed 2017-05-11 |
| 2016-12-31 | -$193.30K 10-K · filed 2018-03-01 |
| 2016-09-30 | -$117.75K 10-Q · filed 2016-11-10 |
| 2016-06-30 | -$133.22K 10-Q · filed 2016-08-11 |
| 2016-03-31 | -$65.79K 10-Q · filed 2016-05-13 |
| 2015-12-31 | -$84.17K 10-K · filed 2017-03-10 |
| 2015-09-30 | -$65.25K 10-Q · filed 2015-11-04 |
| 2015-06-30 | -$79.71K 10-Q · filed 2015-08-11 |
| 2015-03-31 | -$124.97K 10-Q · filed 2015-05-12 |
| 2014-12-31 | -$103.83K 10-K · filed 2016-03-11 |
| 2014-09-30 | -$93.53K 10-Q · filed 2014-11-06 |
| 2014-06-30 | -$73.63K 10-Q · filed 2014-08-01 |
| 2014-03-31 | -$63.99K 10-Q · filed 2014-05-15 |
| 2013-12-31 | -$59.80K 10-K · filed 2015-03-18 |
| 2013-09-30 | -$52.61K 10-Q · filed 2013-10-31 |
| 2013-06-30 | -$46.13K 10-Q · filed 2013-07-29 |
| 2013-03-31 | -$33.26K 10-Q · filed 2013-05-06 |
| 2012-12-31 | -$34.28K 10-K · filed 2014-03-28 |
| 2012-09-30 | -$41.02K 10-Q · filed 2012-11-14 |
| 2012-06-30 | -$34.62K 10-Q · filed 2012-08-14 |
| 2012-03-31 | $1.31K 10-Q · filed 2012-05-15 |
| 2011-12-31 | $4.64K 10-K · filed 2013-04-01 |
| 2010-12-31 | -$39.29K 10-KT/A · filed 2012-05-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |